Citadel Advisors
TECH icon

Citadel Advisors’s Bio-Techne TECH Stock Holding History

Citadel Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5M Buy
67,000
+19,600
+41% +$1.18M ﹤0.01% 4957
2025
Q4 		$2.79M Sell
47,400
-22,300
-32% -$1.35M ﹤0.01% 5308
2025
Q3 		$3.88M Buy
69,700
+10,000
+17% +$536K ﹤0.01% 4816
2025
Q2 		$3.07M Buy
59,700
+52,500
+729% +$2.64M ﹤0.01% 4936
2025
Q1 		$422K Sell
7,200
-25,800
-78% -$1.75M ﹤0.01% 8853
2024
Q4 		$2.38M Sell
33,000
-2,100
-6% -$154K ﹤0.01% 5273
2024
Q3 		$2.81M Sell
35,100
-8,400
-19% -$631K ﹤0.01% 4912
2024
Q2 		$3.12M Buy
43,500
+5,300
+14% +$390K ﹤0.01% 4517
2024
Q1 		$2.69M Buy
38,200
+18,600
+95% +$1.33M ﹤0.01% 4974
2023
Q4 		$1.51M Buy
19,600
+12,200
+165% +$804K ﹤0.01% 5869
2023
Q3 		$504K Sell
7,400
-27,500
-79% -$2.17M ﹤0.01% 8058
2023
Q2 		$2.85M Buy
34,900
+18,200
+109% +$1.46M ﹤0.01% 4557
2023
Q1 		$1.24M Sell
16,700
-13,300
-44% -$1.03M ﹤0.01% 6320
2022
Q4 		$2.49M Sell
30,000
-12,000
-29% -$953K ﹤0.01% 5078
2022
Q3 		$2.98M Buy
42,000
+19,200
+84% +$1.66M ﹤0.01% 4823
2022
Q2 		$1.98M Sell
22,800
-26,000
-53% -$2.44M ﹤0.01% 5571
2022
Q1 		$5.28M Buy
48,800
+800
+2% +$82.5K ﹤0.01% 4066
2021
Q4 		$6.21M Sell
48,000
-17,600
-27% -$2.16M ﹤0.01% 3914
2021
Q3 		$7.95M Buy
65,600
+12,800
+24% +$1.56M ﹤0.01% 3464
2021
Q2 		$5.94M Buy
52,800
+19,200
+57% +$2.02M ﹤0.01% 4077
2021
Q1 		$3.21M Buy
33,600
+9,200
+38% +$839K ﹤0.01% 5270
2020
Q4 		$1.94M Buy
24,400
+12,000
+97% +$869K ﹤0.01% 5415
2020
Q3 		$768K Sell
12,400
-30,000
-71% -$1.95M ﹤0.01% 6522
2020
Q2 		$2.8M Buy
+42,400
New +$2.54M ﹤0.01% 3977
2013
Q4 		– Sell
-4,400
Closed -$88K – 7165
2013
Q3 		$88K Sell
4,400
-400
-8% -$7.59K ﹤0.01% 5428
2013
Q2 		$83K Buy
+4,800
New +$79.7K ﹤0.01% 5351

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors's TECH Position: Q1 2026 in Review

Citadel Advisors reduced its Bio-Techne (TECH) stake by 95% in Q1 2026, selling an estimated $49.4M and leaving 43,402 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #5820.

Citadel Advisors first reported a position in TECH in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q2 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Citadel Advisors held 43,402 shares of Bio-Techne worth $2.27M as of Q1 2026.
  • Citadel Advisors sold 823,318 Bio-Techne shares in Q1 2026, an estimated $49.4M.
  • Bio-Techne made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5820 holding.
  • Citadel Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 51 quarters since.
  • Citadel Advisors's Bio-Techne position peaked at $127M in Q2 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.